Health and Human Services Secretary Tommy G. Thompson today announced a new public-private partnership that joins the National Institutes of Health (NIH), other research organizations, and five pharmaceutical manufacturers. The partners will provide approximately $6 million to cancer centers to design and implement new approaches to increase patient participation in early-stage trials.

Health care professionals, caregivers, and patients all have an important role in symptom management throughout the course of cancer. Evidence suggests that pain is often undertreated, despite the availability of effective interventions. Cancer-related depression and fatigue are less clearly defined, but are extremely common and have a profound impact on patients’ well-being. In the research […]

Researchers from the National Cancer Institute (NCI) have found that women in a large study who used estrogen replacement therapy after menopause were at increased risk for ovarian cancer. The report was published in the July 17, 2002, issue of JAMA.*

The U.S. Preventive Services Task Force, in its strongest ever recommendation for colorectal cancer screening, today urged that all adults age 50 and over get screened for the disease, the nation’s second leading cause of cancer deaths. Various screening tests are available, making it possible for patients and their clinicians to decide which test is […]

Researchers have shown for the first time that individual risk of melanoma, the most serious form of skin cancer, is associated with the intensity of sunlight that a person receives over a lifetime. Published in the journal Cancer Research*, the study also indicates that the risk of melanoma for non-Hispanic whites increases with increased time […]

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has stopped early a major clinical trial of the risks and benefits of combined estrogen and progestin in healthy menopausal women due to an increased risk of invasive breast cancer. The large multi-center trial, a component of the Women’s Health […]